These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5323386)

  • 21. [High-dosed cyclophosphamide therapy of malignant diseases of the lymphoreticulum].
    Kühböck J; Pietschmann H
    Wien Klin Wochenschr; 1965 Nov; 77(44):883-6. PubMed ID: 5328863
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of combined treatment of generalized Hodgkin's disease with several cytostatic agents and corticosteroids].
    Nowak S; Krzyzanowska-Woźniakows ; Lewicka T
    Wiad Lek; 1970 Aug; 23(15):1339-44. PubMed ID: 5457417
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term treatment of advanced lymphogranulomatosis using cytotoxic agents (Velbe, Natulan, Endoxan and Vincristine)].
    Schulz E; Hausmann K
    Verh Dtsch Ges Inn Med; 1968; 74():638-41. PubMed ID: 5714404
    [No Abstract]   [Full Text] [Related]  

  • 24. [Trial of chemotherapy on cancer dissemination and metastasis].
    Franchi G; Donelli MG; Rosso R
    Rev Eur Etud Clin Biol; 1970 Apr; 15(4):453-9. PubMed ID: 5421871
    [No Abstract]   [Full Text] [Related]  

  • 25. Approaches to improving the chemotherapy of Hodgkin's disease.
    Frei E; DeVita VT; Moxley JH; Carbone PP
    Cancer Res; 1966 Jun; 26(6):1284-9. PubMed ID: 5947352
    [No Abstract]   [Full Text] [Related]  

  • 26. [Malignant lymphoma].
    Streuli RA
    Schweiz Rundsch Med Prax; 1981 May; 70(20):909-15. PubMed ID: 7015304
    [No Abstract]   [Full Text] [Related]  

  • 27. [Differing sensitivity to cytostatic drugs in superficial and deep groups of lymph nodes].
    Aggio MC; Alvarez RV; Rocca EO; Bouzat J
    Sangre (Barc); 1970; 15(3):379-82. PubMed ID: 5486765
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combined chemo-radiotherapeutic treatment of breast neoplasms at the metastatis stage].
    Agati G; Stoppa IM
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):803-4. PubMed ID: 5591688
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of treatment with vinblastine of various neoplasms and proliferative syndromes of the lymphoid tissue].
    Polubiec A; Kolakowska-Polubiec K
    Wiad Lek; 1968 Oct; 21(19):1739-42. PubMed ID: 5755333
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclophosphamide for acute leukemia.
    Holland JF
    N Engl J Med; 1969 Apr; 280(16):903. PubMed ID: 5775525
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclophosphamide for acute leukemia.
    Fernbach DJ
    N Engl J Med; 1969 Apr; 280(16):903. PubMed ID: 5775524
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis, staging, and treatment of the malignant lymphomas.
    Golomb HM; Sweet DL
    Compr Ther; 1980 Jul; 6(7):48-56. PubMed ID: 7471681
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytostatic therapy of choroid membrane metastases].
    Müller-Grotjan H; Liegl O
    Klin Monbl Augenheilkd; 1966; 148(6):864-8. PubMed ID: 5987294
    [No Abstract]   [Full Text] [Related]  

  • 34. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiblastic drugs and pregnancy. Apropos of a case treated before and during pregnancy with cyclophosphamide for malignant lymphatic neoplasms and with the birth of a living and lively full-term fetus and followed by another pregnancy with similar result].
    Marazzini F; Macchi L
    Ann Ostet Ginecol Med Perinat; 1966 Nov; 88(11):825-34. PubMed ID: 5996908
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
    Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M
    Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of vincristine sulfate and cyclophosphamide chemotherapy for metastatic neuroblastoma.
    Sullivan MP; Nora AH; Kulapongs P; Lane DM; Windmiller J; Thurman WG
    Pediatrics; 1969 Nov; 44(5):685-94. PubMed ID: 5374979
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 39. [The treatment of chronic hemoblastosis with new cytostatic agents].
    Quattrin N
    Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017
    [No Abstract]   [Full Text] [Related]  

  • 40. [Problems of clinical cancerology: cytostatic shock with cyclophosphamide].
    Cittadini G
    Minerva Med; 1966 May; 57(39):1715-23. PubMed ID: 5939618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.